Lab
Southern California Permanente Medical Group
Southern California Permanente Medical Group was paid $50.89M by Medicaid between Jan 2018 and Dec 2024, across 492 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 11% of everything it billed.
33Billing provider infoSOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP
CHINO HILLS, CA 91709
CHINO HILLS, CA 91709
33aNPI1396287082assigned 11/10/2016
33bProvider typeClinical Medical Laboratory
28Total paid$50.89M
24GClaims10,212,563
24DCodes billed492
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#19 of 561
Median peer was paid$222K
This provider vs. median229×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAVIDOFF, RAMIN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,077,435 | $65K | |
| 2019 | 977,555 | $277K | |
| 2020 | 929,821 | $3.63M | |
| 2021 | 1,511,116 | $7.31M | |
| 2022 | 1,646,832 | $8.13M | |
| 2023 | 1,850,353 | $9.28M | |
| 2024incomplete | 2,219,451 | $22.20M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 11% | 551,168 | 503,862 | $5.52M |
| 83036 | Hemoglobin; glycosylated (A1C) | 7.8% | 773,458 | 765,131 | $3.95M |
| 84443 | Thyroid stimulating hormone (TSH) | 6.6% | 478,667 | 473,273 | $3.38M |
| 80061 | Lipid panel | 5.9% | 484,731 | 481,687 | $3.02M |
| 82565 | 4.2% | 657,703 | 639,015 | $2.13M | |
| 80051 | 3.3% | 433,202 | 421,654 | $1.67M | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.1% | 59,300 | 47,245 | $1.58M |
| 85027 | 2.9% | 559,970 | 555,340 | $1.50M | |
| 81513 | 2.8% | 64,229 | 61,996 | $1.43M | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.7% | 227,963 | 214,774 | $1.36M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.7% | 227,629 | 214,481 | $1.35M |
| 84460 | 2.6% | 507,318 | 499,463 | $1.32M |
480 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.2% | 229,780 | $1.11M |
| 83970 | 1.9% | 33,482 | $970K | |
| 87088 | 1.9% | 284,948 | $955K | |
| 82274 | 1.7% | 95,503 | $887K | |
| 82043 | 1.7% | 194,552 | $867K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.7% | 71,429 | $845K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.6% | 31,640 | $796K |
| 82728 | 1.5% | 123,290 | $763K | |
| 82607 | 1.5% | 88,943 | $761K | |
| 87481 | 1.4% | 63,936 | $716K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.4% | 63,719 | $710K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.4% | 136,724 | $694K |
| 84153 | 1.3% | 45,861 | $646K | |
| 86803 | 1.1% | 120,899 | $559K | |
| 84439 | 1.0% | 127,423 | $516K | |
| 83550 | <1% | 116,479 | $465K | |
| 86780 | <1% | 149,004 | $434K | |
| 82310 | <1% | 104,341 | $421K | |
| 82746 | <1% | 42,730 | $397K | |
| 86141 | <1% | 53,848 | $388K | |
| 87505 | <1% | 8,362 | $378K | |
| 87186 | <1% | 78,611 | $375K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 15,196 | $356K |
| 84075 | <1% | 139,756 | $353K | |
| 82247 | <1% | 142,237 | $344K | |
| 83540 | <1% | 118,761 | $335K | |
| 84403 | <1% | 32,688 | $299K | |
| 84132 | <1% | 90,944 | $296K | |
| 84520 | <1% | 127,518 | $276K | |
| 84450 | <1% | 112,813 | $267K | |
| 87340 | <1% | 113,249 | $251K | |
| 83721 | <1% | 51,072 | $248K | |
| 82947 | <1% | 158,008 | $228K | |
| 84295 | <1% | 66,005 | $223K | |
| 82040 | <1% | 70,081 | $214K | |
| 87536 | <1% | 6,359 | $205K | |
| 88342 | <1% | 5,589 | $157K | |
| 87522 | Neg quan hep c or qual rna | <1% | 7,675 | $146K |
| 83735 | <1% | 42,065 | $139K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 2,685 | $131K |
| 84100 | <1% | 44,726 | $130K | |
| 85014 | <1% | 62,376 | $124K | |
| 87529 | <1% | 9,854 | $124K | |
| 85018 | <1% | 52,517 | $119K | |
| 85652 | <1% | 74,582 | $118K | |
| 88341 | <1% | 2,931 | $116K | |
| 82105 | <1% | 9,553 | $108K | |
| 82378 | <1% | 6,574 | $106K | |
| 83718 | <1% | 30,106 | $105K | |
| 87081 | <1% | 125,985 | $97K | |
| 87517 | <1% | 3,377 | $91K | |
| 82670 | <1% | 17,859 | $91K | |
| 87070 | <1% | 28,904 | $90K | |
| 83520 | <1% | 12,363 | $84K | |
| 86317 | <1% | 20,982 | $84K | |
| 83001 | <1% | 24,862 | $83K | |
| 87497 | <1% | 1,766 | $82K | |
| 86704 | <1% | 16,322 | $76K | |
| 82024 | <1% | 4,241 | $69K | |
| 84550 | <1% | 30,698 | $64K | |
| 86304 | <1% | 4,803 | $61K | |
| 84480 | <1% | 15,114 | $58K | |
| 82627 | <1% | 11,948 | $56K | |
| 82465 | <1% | 34,322 | $55K | |
| 84270 | <1% | 9,393 | $55K | |
| 84134 | <1% | 8,053 | $53K | |
| 86762 | <1% | 29,959 | $51K | |
| 86787 | <1% | 30,953 | $49K | |
| 88312 | <1% | 2,473 | $48K | |
| 82533 | <1% | 7,891 | $46K | |
| 83002 | <1% | 13,961 | $46K | |
| 86376 | <1% | 10,275 | $44K | |
| 86300 | <1% | 3,159 | $42K | |
| 86301 | <1% | 2,106 | $39K | |
| 82550 | <1% | 13,338 | $39K | |
| 82248 | <1% | 15,838 | $39K | |
| 86360 | <1% | 891 | $38K | |
| 88304 | <1% | 4,995 | $37K | |
| 86431 | <1% | 16,906 | $37K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 9,575 | $35K |
| 87902 | <1% | 142 | $35K | |
| 85046 | <1% | 7,803 | $33K | |
| 87040 | <1% | 8,362 | $31K | |
| 86359 | <1% | 893 | $30K | |
| 86765 | <1% | 16,904 | $30K | |
| 86769 | <1% | 5,941 | $24K | |
| 82977 | <1% | 7,424 | $24K | |
| 86696 | <1% | 7,338 | $22K | |
| 88185 | <1% | 50 | $22K | |
| 86708 | <1% | 5,246 | $22K | |
| 88313 | <1% | 157 | $20K | |
| 83090 | <1% | 2,110 | $18K | |
| 83880 | <1% | 239 | $18K | |
| 86705 | <1% | 1,709 | $18K | |
| 86735 | <1% | 9,519 | $16K | |
| 88307 | <1% | 668 | $16K | |
| 87493 | <1% | 712 | $15K | |
| 86695 | <1% | 7,340 | $15K | |
| 86635 | <1% | 2,829 | $14K | |
| 84681 | <1% | 2,255 | $13K | |
| 86709 | <1% | 4,615 | $13K | |
| 87185 | <1% | 10,395 | $13K | |
| 84478 | <1% | 5,282 | $12K | |
| 84144 | <1% | 3,071 | $12K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,561 | $12K |
| 84702 | <1% | 4,138 | $11K | |
| 85045 | <1% | 3,034 | $11K | |
| 86665 | <1% | 5,309 | $11K | |
| 86592 | <1% | 9,471 | $10K | |
| 84155 | <1% | 5,403 | $10K | |
| 87147 | <1% | 8,323 | $10K | |
| 82150 | <1% | 4,824 | $9K | |
| 87075 | <1% | 1,553 | $8K | |
| 82164 | <1% | 1,079 | $8K | |
| 83525 | <1% | 3,669 | $8K | |
| 82340 | <1% | 1,905 | $7K | |
| 82570 | <1% | 2,170 | $6K | |
| 87046 | <1% | 1,923 | $6K | |
| 84146 | <1% | 5,382 | $6K | |
| 86677 | <1% | 4,884 | $6K | |
| 82232 | <1% | 256 | $6K | |
| 82530 | <1% | 863 | $6K | |
| 85049 | <1% | 1,805 | $6K | |
| 82985 | <1% | 1,068 | $6K | |
| 87184 | <1% | 438 | $5K | |
| 86664 | <1% | 2,647 | $5K | |
| 88184 | <1% | 52 | $5K | |
| 86593 | <1% | 3,479 | $4K | |
| 84466 | <1% | 372 | $3K | |
| 84999 | <1% | 26 | $3K | |
| 82435 | <1% | 1,443 | $3K | |
| 84540 | <1% | 451 | $2K | |
| 86355 | <1% | 62 | $2K | |
| 86357 | <1% | 62 | $2K | |
| 82374 | <1% | 729 | $2K | |
| 86702 | <1% | 205 | $977.23 | |
| 86060 | <1% | 388 | $933.23 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 359 | $931.19 |
| 86701 | <1% | 205 | $596.33 | |
| 87045 | <1% | 744 | $520.43 | |
| 87593 | <1% | 46 | $468.00 | |
| 87205 | <1% | 165 | $448.50 | |
| 84154 | <1% | 12 | $315.00 | |
| 83529 | <1% | 14 | $180.00 | |
| 80400 | <1% | 12 | $170.00 | |
| 86140 | <1% | 5,233 | $137.40 | |
| 82945 | <1% | 386 | $100.00 | |
| 86800 | <1% | 13 | $80.00 | |
| 87631 | <1% | 106 | $54.96 | |
| 99283 | Emergency room visit (moderate) | <1% | 3,502 | $44.60 |
| 84163 | <1% | 127 | $13.37 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 0% | 1,424 | $0.00 |
| 3044F | 0% | 181,091 | $0.00 | |
| 97165 | 0% | 204 | $0.00 | |
| 3052F | 0% | 12,889 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 20,567 | $0.00 |
| 92567 | 0% | 322 | $0.00 | |
| 71101 | 0% | 172 | $0.00 | |
| 73560 | 0% | 320 | $0.00 | |
| 82784 | 0% | 302 | $0.00 | |
| 99213 | Doctor's office visit, returning patient (routine) | 0% | 54,638 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 426 | $0.00 |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 0% | 288 | $0.00 |
| 99205 | Prolong outpt/office vis | 0% | 347 | $0.00 |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 0% | 2,072 | $0.00 |
| 11900 | 0% | 170 | $0.00 | |
| 73090 | 0% | 379 | $0.00 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 844 | $0.00 |
| 90656 | 0% | 1,277 | $0.00 | |
| 90834 | Psychotherapy session, about 45 minutes | 0% | 4,138 | $0.00 |
| 82950 | 0% | 41 | $0.00 | |
| 92523 | 0% | 360 | $0.00 | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 0% | 309 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 30,941 | $0.00 |
| 99239 | Hospital discharge day management, more than 30 minutes | 0% | 18 | $0.00 |
| 3074F | 0% | 5,425 | $0.00 | |
| 76536 | 0% | 382 | $0.00 | |
| 90739 | 0% | 60 | $0.00 | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 0% | 239 | $0.00 |
| 85379 | 0% | 55 | $0.00 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 0% | 359 | $0.00 |
| 99232 | Hospital visit by a doctor, follow-up day | 0% | 170 | $0.00 |
| 90744 | 0% | 129 | $0.00 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 1,392 | $0.00 |
| 90651 | 0% | 1,996 | $0.00 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 335 | $0.00 |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 0% | 371 | $0.00 |
| 90686 | 0% | 7,662 | $0.00 | |
| 20550 | 0% | 103 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,143 | $0.00 |
| 73522 | 0% | 24 | $0.00 | |
| 20610 | 0% | 474 | $0.00 | |
| 17000 | 0% | 121 | $0.00 | |
| 73660 | 0% | 306 | $0.00 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 0% | 189 | $0.00 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 0% | 223 | $0.00 |
| 90732 | 0% | 373 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 56 | $0.00 |
| 83021 | 0% | 142 | $0.00 | |
| 99385 | 0% | 218 | $0.00 | |
| 97166 | 0% | 61 | $0.00 | |
| 70486 | 0% | 147 | $0.00 | |
| 99217 | 0% | 283 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 1,538 | $0.00 |
| 87255 | 0% | 145 | $0.00 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 0% | 298 | $0.00 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 366 | $0.00 |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 0% | 718 | $0.00 |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 0% | 172 | $0.00 |
| 58100 | 0% | 172 | $0.00 | |
| 76641 | 0% | 508 | $0.00 | |
| 86580 | 0% | 1,335 | $0.00 | |
| 11055 | 0% | 146 | $0.00 | |
| 84484 | 0% | 186 | $0.00 | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 0% | 230 | $0.00 |
| 90696 | 0% | 689 | $0.00 | |
| 72081 | 0% | 373 | $0.00 | |
| 92551 | 0% | 7,783 | $0.00 | |
| 96127 | 0% | 150 | $0.00 | |
| 76870 | 0% | 215 | $0.00 | |
| 97162 | 0% | 110 | $0.00 | |
| 73120 | 0% | 151 | $0.00 | |
| 83690 | 0% | 529 | $0.00 | |
| 76801 | 0% | 182 | $0.00 | |
| 97010 | 0% | 426 | $0.00 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 0% | 65 | $0.00 |
| 83921 | 0% | 44 | $0.00 | |
| 58301 | 0% | 161 | $0.00 | |
| 83605 | 0% | 178 | $0.00 | |
| 76830 | Ultrasound, transvaginal | 0% | 1,305 | $0.00 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 522 | $0.00 |
| 93971 | 0% | 164 | $0.00 | |
| 92227 | 0% | 797 | $0.00 | |
| 95806 | 0% | 103 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 3,642 | $0.00 |
| 99383 | 0% | 14 | $0.00 | |
| 90723 | 0% | 2,049 | $0.00 | |
| 82962 | 0% | 492 | $0.00 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 0% | 540 | $0.00 |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 0% | 1,263 | $0.00 |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 0% | 129 | $0.00 |
| 73564 | 0% | 935 | $0.00 | |
| 73502 | 0% | 470 | $0.00 | |
| 94660 | 0% | 45 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 0% | 1,031 | $0.00 |
| 92002 | 0% | 2,121 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 3,862 | $0.00 |
| 99460 | 0% | 30 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 218 | $0.00 |
| 73060 | 0% | 52 | $0.00 | |
| 74183 | 0% | 13 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 457 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 1,641 | $0.00 |
| 71045 | Radiologic examination, chest; single view | 0% | 1,204 | $0.00 |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 0% | 73 | $0.00 |
| 86225 | 0% | 127 | $0.00 | |
| 94010 | 0% | 105 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 386 | $0.00 |
| L1810 | Knee orthosis, elastic with joints, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | 0% | 57 | $0.00 |
| 12001 | 0% | 54 | $0.00 | |
| 82677 | 0% | 295 | $0.00 | |
| 94761 | 0% | 261 | $0.00 | |
| 90716 | 0% | 935 | $0.00 | |
| 52000 | 0% | 76 | $0.00 | |
| 57454 | 0% | 55 | $0.00 | |
| 85730 | 0% | 59 | $0.00 | |
| 86885 | 0% | 119 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 18 | $0.00 |
| 99441 | 0% | 4,966 | $0.00 | |
| 74022 | 0% | 71 | $0.00 | |
| 72040 | 0% | 348 | $0.00 | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 0% | 189 | $0.00 |
| 58300 | 0% | 180 | $0.00 | |
| 73650 | 0% | 23 | $0.00 | |
| 29075 | 0% | 12 | $0.00 | |
| 51798 | 0% | 109 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 106 | $0.00 |
| 96415 | 0% | 113 | $0.00 | |
| 93227 | 0% | 45 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 57 | $0.00 |
| 73221 | 0% | 130 | $0.00 | |
| 90632 | 0% | 43 | $0.00 | |
| 92587 | 0% | 61 | $0.00 | |
| 11200 | 0% | 27 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 129 | $0.00 |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 0% | 25 | $0.00 |
| 99285 | Emergency room visit (most serious) | 0% | 1,233 | $0.00 |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 0% | 28 | $0.00 |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 0% | 14 | $0.00 |
| 95910 | 0% | 12 | $0.00 | |
| 99386 | 0% | 44 | $0.00 | |
| 20553 | 0% | 15 | $0.00 | |
| 64615 | 0% | 14 | $0.00 | |
| 80197 | 0% | 34 | $0.00 | |
| 70491 | 0% | 13 | $0.00 | |
| 31231 | 0% | 91 | $0.00 | |
| 86160 | 0% | 53 | $0.00 | |
| 97597 | 0% | 15 | $0.00 | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 0% | 23 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 16 | $0.00 |
| 99220 | 0% | 12 | $0.00 | |
| 94760 | 0% | 21 | $0.00 | |
| 86901 | 0% | 136 | $0.00 | |
| 95819 | 0% | 12 | $0.00 | |
| 96150 | 0% | 13 | $0.00 | |
| 11730 | 0% | 13 | $0.00 | |
| 73552 | 0% | 23 | $0.00 | |
| 86336 | 0% | 296 | $0.00 | |
| 3051F | 0% | 21,389 | $0.00 | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 0% | 115 | $0.00 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 0% | 419 | $0.00 |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 0% | 333 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 6,271 | $0.00 |
| 99442 | 0% | 533 | $0.00 | |
| 77080 | 0% | 462 | $0.00 | |
| 73610 | 0% | 1,647 | $0.00 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 0% | 238 | $0.00 |
| 90710 | 0% | 707 | $0.00 | |
| 86003 | 0% | 875 | $0.00 | |
| 85610 | 0% | 732 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 3,426 | $0.00 |
| 71250 | 0% | 96 | $0.00 | |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 0% | 295 | $0.00 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 4,808 | $0.00 |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 0% | 1,107 | $0.00 |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 3,431 | $0.00 |
| 73562 | 0% | 1,303 | $0.00 | |
| 73130 | 0% | 994 | $0.00 | |
| 99219 | 0% | 348 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 160 | $0.00 |
| 73110 | 0% | 1,030 | $0.00 | |
| 73140 | 0% | 1,059 | $0.00 | |
| 99173 | 0% | 9,336 | $0.00 | |
| 90791 | Psychiatric diagnostic evaluation | 0% | 1,288 | $0.00 |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 0% | 893 | $0.00 |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | 0% | 139 | $0.00 |
| 78815 | Positron emission tomography (PET) for limited area imaging | 0% | 15 | $0.00 |
| 90715 | 0% | 1,779 | $0.00 | |
| 11100 | 0% | 218 | $0.00 | |
| 90713 | 0% | 143 | $0.00 | |
| 3046F | 0% | 17,763 | $0.00 | |
| 90707 | 0% | 955 | $0.00 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 4,992 | $0.00 |
| 83655 | 0% | 1,478 | $0.00 | |
| 3078F | 0% | 5,205 | $0.00 | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 0% | 322 | $0.00 |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 0% | 55 | $0.00 |
| 76770 | 0% | 605 | $0.00 | |
| 73030 | 0% | 1,237 | $0.00 | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | 0% | 850 | $0.00 |
| 90633 | 0% | 1,709 | $0.00 | |
| 92579 | 0% | 112 | $0.00 | |
| 90681 | 0% | 946 | $0.00 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 4,476 | $0.00 |
| 71046 | Radiologic examination, chest; 2 views | 0% | 4,625 | $0.00 |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 571 | $0.00 |
| 90661 | 0% | 1,655 | $0.00 | |
| 87102 | 0% | 56 | $0.00 | |
| 90734 | 0% | 1,544 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 1,360 | $0.00 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 174 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 330 | $0.00 |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 281 | $0.00 |
| 76813 | 0% | 144 | $0.00 | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 0% | 1,688 | $0.00 |
| 74018 | 0% | 1,127 | $0.00 | |
| 86038 | 0% | 134 | $0.00 | |
| 86235 | 0% | 15 | $0.00 | |
| 92015 | Determination of refractive state | 0% | 3,570 | $0.00 |
| 20552 | 0% | 115 | $0.00 | |
| 96101 | 0% | 62 | $0.00 | |
| 81002 | 0% | 3,600 | $0.00 | |
| 31575 | 0% | 125 | $0.00 | |
| 80164 | 0% | 43 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 611 | $0.00 |
| 92550 | 0% | 160 | $0.00 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 0% | 1,512 | $0.00 |
| 90648 | 0% | 3,001 | $0.00 | |
| 69209 | 0% | 42 | $0.00 | |
| 72141 | 0% | 172 | $0.00 | |
| 90670 | 0% | 3,151 | $0.00 | |
| 73070 | 0% | 258 | $0.00 | |
| 11750 | 0% | 130 | $0.00 | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 0% | 867 | $0.00 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 1,730 | $0.00 |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 3,672 | $0.00 |
| 90837 | Psychotherapy session, about an hour | 0% | 1,902 | $0.00 |
| 77066 | Tomosynthesis, mammo | 0% | 80 | $0.00 |
| 90691 | 0% | 115 | $0.00 | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 0% | 224 | $0.00 |
| 10060 | 0% | 74 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 832 | $0.00 |
| 17110 | 0% | 611 | $0.00 | |
| 85060 | 0% | 80 | $0.00 | |
| J1071 | Injection, testosterone cypionate, 1 mg | 0% | 306 | $0.00 |
| 76857 | 0% | 184 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 312 | $0.00 |
| 99225 | 0% | 232 | $0.00 | |
| 11721 | 0% | 258 | $0.00 | |
| 90658 | 0% | 745 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 4,130 | $0.00 |
| 81003 | 0% | 2,044 | $0.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 12,578 | $0.00 |
| 90685 | 0% | 84 | $0.00 | |
| 90746 | 0% | 418 | $0.00 | |
| 99201 | 0% | 1,246 | $0.00 | |
| 73630 | 0% | 2,265 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 1,142 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 302 | $0.00 |
| 76881 | 0% | 126 | $0.00 | |
| 43235 | 0% | 169 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 3,276 | $0.00 |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 1,914 | $0.00 |
| 62323 | 0% | 45 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 1,022 | $0.00 |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 0% | 3,312 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 521 | $0.00 |
| 72050 | 0% | 159 | $0.00 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 1,852 | $0.00 |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 0% | 581 | $0.00 |
| 12011 | 0% | 28 | $0.00 | |
| 90750 | 0% | 45 | $0.00 | |
| 73590 | 0% | 399 | $0.00 | |
| 73100 | 0% | 338 | $0.00 | |
| 99284 | Emergency room visit (serious) | 0% | 4,417 | $0.00 |
| 99222 | Initial hospital care, per day, moderate complexity | 0% | 35 | $0.00 |
| 86900 | 0% | 137 | $0.00 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 0% | 914 | $0.00 |
| L1902 | Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf | 0% | 49 | $0.00 |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 0% | 170 | $0.00 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 701 | $0.00 |
| 87210 | 0% | 56 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 471 | $0.00 |
| 96523 | 0% | 28 | $0.00 | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 0% | 327 | $0.00 |
| 97161 | 0% | 1,641 | $0.00 | |
| 86256 | 0% | 48 | $0.00 | |
| 92134 | 0% | 147 | $0.00 | |
| 87341 | 0% | 59 | $0.00 | |
| 17003 | 0% | 14 | $0.00 | |
| 87338 | 0% | 62 | $0.00 | |
| L3260 | Surgical boot/shoe, each | 0% | 26 | $0.00 |
| Q5102 | Injection, infliximab, biosimilar, 10 mg | 0% | 15 | $0.00 |
| 92557 | 0% | 217 | $0.00 | |
| 73080 | 0% | 424 | $0.00 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 0% | 41 | $0.00 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 0% | 536 | $0.00 |
| 72100 | 0% | 813 | $0.00 | |
| 90700 | 0% | 869 | $0.00 | |
| 94060 | 0% | 61 | $0.00 | |
| 70450 | Computed tomography, head or brain; without contrast material | 0% | 640 | $0.00 |
| 72070 | 0% | 56 | $0.00 | |
| 93970 | 0% | 39 | $0.00 | |
| 81025 | 0% | 2,487 | $0.00 | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 0% | 19 | $0.00 |
| 92504 | 0% | 12 | $0.00 | |
| 99051 | 0% | 1,310 | $0.00 | |
| 77072 | 0% | 24 | $0.00 | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 0% | 15 | $0.00 |
| 99354 | 0% | 12 | $0.00 | |
| 80076 | 0% | 13 | $0.00 | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | 0% | 32 | $0.00 |
| 00840 | 0% | 50 | $0.00 | |
| 67028 | Intravitreal injection of a pharmacologic agent | 0% | 17 | $0.00 |
| 84305 | 0% | 13 | $0.00 | |
| 86147 | 0% | 13 | $0.00 | |
| 96417 | 0% | 54 | $0.00 | |
| 86480 | 0% | 47 | $0.00 | |
| 97760 | 0% | 15 | $0.00 | |
| 99238 | Hospital discharge day management, 30 minutes or less | 0% | 63 | $0.00 |
| 99223 | Prolong inpt eval add15 m | 0% | 14 | $0.00 |
| 47562 | 0% | 12 | $0.00 | |
| 80361 | 0% | 18 | $0.00 | |
| 92133 | 0% | 51 | $0.00 | |
| 99221 | 0% | 37 | $0.00 | |
| 90785 | 0% | 28 | $0.00 | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 0% | 66 | $0.00 |
| 86039 | 0% | 15 | $0.00 | |
| J9035 | Injection, bevacizumab, 10 mg | 0% | 13 | $0.00 |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIDOFF, RAMIN (EXECUTIVE MEDICAL DIRECTOR)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.